{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:48:20Z","timestamp":1790711300684,"version":"4.1.0"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.tube.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T03:31:33Z","timestamp":1548127893000},"page":"26-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Tuberculosis vaccine candidates based on mycobacterial cell envelope components"],"prefix":"10.1016","volume":"115","author":[{"given":"M.E.","family":"Sarmiento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.Z.","family":"Anis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-6441","authenticated-orcid":false,"given":"M.N.","family":"Norazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2019.01.003_bib1","series-title":"Global tuberculosis report 2017","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.tube.2019.01.003_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2018.00158","article-title":"Mycobacterium tuberculosis: an adaptable pathogen associated with multiple human diseases","volume":"8","author":"Chai","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/resp.13245","article-title":"Tuberculosis vaccines: opportunities and challenges","volume":"23","author":"Zhu","year":"2018","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib4","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2334-14-S1-S2","article-title":"Vaccine against tuberculosis: what's new?","volume":"14","author":"Montagnani","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"8986","key":"10.1016\/j.tube.2019.01.003_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"1\u20133","key":"10.1016\/j.tube.2019.01.003_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1472-9792(02)00089-6","article-title":"Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis","volume":"83","author":"Brennan","year":"2003","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2019.01.003_bib7","first-page":"131","article-title":"The envelope layers of mycobacteria with reference to their pathogenicity","volume":"vol. 39","author":"Daff\u00e9","year":"1997"},{"issue":"03","key":"10.1016\/j.tube.2019.01.003_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3855\/jidc.3114","article-title":"Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosis","volume":"7","author":"Morandi","year":"2013","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.tube.2019.01.003_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-2164(09)69002-X","article-title":"Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis","volume":"69","author":"Kaur","year":"2009","journal-title":"Adv Appl Microbiol"},{"key":"10.1016\/j.tube.2019.01.003_bib10","first-page":"95","article-title":"Complex lipids, their chemistry biosynthesis and roles","volume":"1","author":"Minnikin","year":"1982","journal-title":"Biol. Mycobact."},{"key":"10.1016\/j.tube.2019.01.003_bib11","first-page":"3","article-title":"1 the global architecture of the mycobacterial cell envelope. The mycobacterial cell envelope","author":"Daff\u00e9","year":"2008","journal-title":"Am. Soc. Microbiol."},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.bi.64.070195.000333","article-title":"The envelope of mycobacteria","volume":"64","author":"Brennan","year":"1995","journal-title":"Annu Rev Biochem"},{"issue":"14","key":"10.1016\/j.tube.2019.01.003_bib13","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1073\/pnas.92.14.6630","article-title":"Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis","volume":"92","author":"Yuan","year":"1995","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib14","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1529\/biophysj.107.125542","article-title":"The Mycobacterium tuberculosis virulence factor trehalose dimycolate imparts desiccation resistance to model mycobacterial membranes","volume":"94","author":"Harland","year":"2008","journal-title":"Biophys J"},{"key":"10.1016\/j.tube.2019.01.003_bib15","first-page":"123","article-title":"Lipid adjuvants and antigens embedded in the mycobacterial cell envelope","author":"Kasmar","year":"2014","journal-title":"Art Sci. Tuberc. Vaccine Dev."},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1054\/tuld.1998.0200","article-title":"The capsule of Mycobacterium tuberculosis and its implications for pathogenicity","volume":"79","author":"Daffe","year":"1999","journal-title":"Tuber Lung Dis"},{"issue":"10","key":"10.1016\/j.tube.2019.01.003_bib17","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1128\/IAI.72.10.5676-5686.2004","article-title":"The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages","volume":"72","author":"Stokes","year":"2004","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1462-5822.2003.00289.x","article-title":"Deficiency in mycolipenate\u2010and mycosanoate\u2010derived acyltrehaloses enhances early interactions of Mycobacterium tuberculosis with host cells","volume":"5","author":"Rousseau","year":"2003","journal-title":"Cell Microbiol"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1099\/00221287-142-4-927","article-title":"The outermost capsular arabinomannans and other mannoconjugates of virulent and avirulent tubercle bacilli","volume":"142","author":"Ortalo-Magne","year":"1996","journal-title":"Microbiology"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib20","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.4049\/jimmunol.170.5.2409","article-title":"The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2","volume":"170","author":"L\u00f3pez","year":"2003","journal-title":"J Immunol"},{"issue":"41","key":"10.1016\/j.tube.2019.01.003_bib21","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1016\/j.vaccine.2007.07.042","article-title":"A mutant of Mycobacterium tuberculosis lacking the 19-kDa lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties","volume":"25","author":"Henao-Tamayo","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2019.01.003_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2017.08.040","article-title":"Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design","volume":"112","author":"Babaki","year":"2017","journal-title":"Microb Pathog"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1574-6976.2011.00276.x","article-title":"Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host\u2013pathogen interaction","volume":"35","author":"Mishra","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.tube.2019.01.003_bib24","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.2741\/A372","article-title":"Relationships between the structure and the roles of lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis","volume":"3","author":"Vercellone","year":"1998","journal-title":"Front Biosci"},{"key":"10.1016\/j.tube.2019.01.003_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021113","article-title":"The Mycobacterial cell wall\u2014peptidoglycan and arabinogalactan","author":"Alderwick","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","article-title":"Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis","volume":"18","author":"Takayama","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib27","first-page":"371","article-title":"Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease","volume":"36","author":"Hunter","year":"2006","journal-title":"Ann Clin Lab Sci"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0966-842X(01)02018-2","article-title":"Interpreting cell wall \u2018virulence factors\u2019 of Mycobacterium tuberculosis","volume":"9","author":"Barry","year":"2001","journal-title":"Trends Microbiol"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000289","article-title":"Phthiocerol dimycocerosates of M. tuberculosis participate in macrophage invasion by inducing changes in the organization of plasma membrane lipids","volume":"5","author":"Astarie-Dequeker","year":"2009","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib30","article-title":"The cell wall lipid PDIM contributes to phagosomal escape and host cell exit of","volume":"8","author":"Quigley","year":"2017","journal-title":"Mycobact. Tuberc. MBio."},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02703614","article-title":"Immunoprophylactic studies on cell wall associated proteins ofMycobacterium tuberculosis H 37 Ra","volume":"22","author":"Dhiman","year":"1997","journal-title":"J Biosci"},{"key":"10.1016\/j.tube.2019.01.003_bib32","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M117.811190","article-title":"The transpeptidase PbpA and non-canonical transglycosylase RodA of Mycobacterium tuberculosis play important roles in regulating bacterial cell lengths","author":"Arora","year":"2018","journal-title":"J Biol Chem"},{"issue":"42","key":"10.1016\/j.tube.2019.01.003_bib33","doi-asserted-by":"crossref","first-page":"13087","DOI":"10.1073\/pnas.1514135112","article-title":"Peptidoglycan synthesis in Mycobacterium tuberculosis is organized into networks with varying drug susceptibility","volume":"112","author":"Kieser","year":"2015","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"9","key":"10.1016\/j.tube.2019.01.003_bib34","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.189.9.1425","article-title":"An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets","volume":"189","author":"Harth","year":"1999","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1128\/iai.57.2.322-330.1989","article-title":"Phenolic glycolipids of Mycobacterium bovis: new structures and synthesis of a corresponding seroreactive neoglycoprotein","volume":"57","author":"Chatterjee","year":"1989","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/1389203717666160729093515","article-title":"The \u03b1\/\u03b2 hydrolase fold proteins of Mycobacterium tuberculosis, with reference to their contribution to virulence","volume":"18","author":"Johnson","year":"2017","journal-title":"Curr Protein Pept Sci"},{"issue":"15","key":"10.1016\/j.tube.2019.01.003_bib37","doi-asserted-by":"crossref","first-page":"E3378","DOI":"10.1073\/pnas.1717015115","article-title":"IpdAB, a virulence factor in Mycobacterium tuberculosis, is a cholesterol ring-cleaving hydrolase","volume":"115","author":"Crowe","year":"2018","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"23","key":"10.1016\/j.tube.2019.01.003_bib38","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.0503272102","article-title":"Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages","volume":"102","author":"Rengarajan","year":"2005","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00321-17","article-title":"Catabolism of the last two steroid rings in Mycobacterium tuberculosis and other bacteria","volume":"8","author":"Crowe","year":"2017","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib40","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1038\/s41598-018-22012-6","article-title":"In vivo virulence of Mycobacterium tuberculosis depends on a single homologue of the LytR-CpsA-Psr proteins","volume":"8","author":"Malm","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.tube.2019.01.003_bib41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/acsinfecdis.6b00092","article-title":"Design of selective substrates and activity-based probes for Hydrolase Important for Pathogenesis 1 (HIP1) from Mycobacterium tuberculosis","volume":"2","author":"Lentz","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.tube.2019.01.003_bib42","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1303185","article-title":"Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1","author":"Madan-Lala","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2019.01.003_bib43","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021105","article-title":"The mycobacterial cell envelope\u2014lipids","author":"Jackson","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib44","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4067\/S0034-98872011001200012","article-title":"Factores de virulencia de Mycobacterium tuberculosis","volume":"139","author":"Maul\u00e9n","year":"2011","journal-title":"Rev Med Chile"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/viru.22329","article-title":"Virulence factors of the Mycobacterium tuberculosis complex","volume":"4","author":"Forrellad","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.tube.2019.01.003_bib46","article-title":"Biosynthesis and virulent behavior of lipids produced by Mycobacterium tuberculosis: LAM and cord factor: an overview","volume":"2011","author":"Rao","year":"2011","journal-title":"Biotechnol. Res. Int."},{"key":"10.1016\/j.tube.2019.01.003_bib47","doi-asserted-by":"crossref","first-page":"21624","DOI":"10.1038\/srep21624","article-title":"PE11, a PE\/PPE family protein of Mycobacterium tuberculosis is involved in cell wall remodeling and virulence","volume":"6","author":"Singh","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2958.2008.06274.x","article-title":"Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug\u2010tolerant bacteria","volume":"69","author":"Ojha","year":"2008","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib49","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/eji.201040719","article-title":"Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern","volume":"41","author":"Vander Beken","year":"2011","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib50","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1073\/pnas.0608654104","article-title":"Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice","volume":"104","author":"Bhatt","year":"2007","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"38","key":"10.1016\/j.tube.2019.01.003_bib51","doi-asserted-by":"crossref","first-page":"36637","DOI":"10.1074\/jbc.M305427200","article-title":"Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii novel structural features and apoptosis-inducing properties","volume":"278","author":"Gu\u00e9rardel","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib52","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2958.2004.04183.x","article-title":"Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response","volume":"53","author":"Briken","year":"2004","journal-title":"Mol Microbiol"},{"issue":"52","key":"10.1016\/j.tube.2019.01.003_bib53","doi-asserted-by":"crossref","first-page":"42794","DOI":"10.1074\/jbc.M506471200","article-title":"Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages","volume":"280","author":"Pathak","year":"2005","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib54","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.4049\/jimmunol.166.12.7477","article-title":"Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor","volume":"166","author":"Nigou","year":"2001","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.tube.2019.01.003_bib55","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1073\/pnas.0409716102","article-title":"Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis","volume":"102","author":"Vergne","year":"2005","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.tube.2019.01.003_bib56","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.tube.2016.09.023","article-title":"Cord factor as an invisibility cloak? A hypothesis for asymptomatic TB persistence","volume":"101","author":"Hunter","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2019.01.003_bib57","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1472-9792(09)70007-1","article-title":"TB research at UT-Houston\u2013a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis","volume":"89","author":"Hunter","year":"2009","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib58","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/iai.56.12.3067-3071.1988","article-title":"Tumor necrosis factor (cachectin) mediates induction of cachexia by cord factor from mycobacteria","volume":"56","author":"Silva","year":"1988","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20041668","article-title":"Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule","volume":"201","author":"Rao","year":"2005","journal-title":"J Exp Med"},{"issue":"7004","key":"10.1016\/j.tube.2019.01.003_bib60","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature02837","article-title":"A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response","volume":"431","author":"Reed","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tube.2019.01.003_bib61","first-page":"63","article-title":"Mycobacterial lipids: chemistry and biologic activities","author":"Goren","year":"1979","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2019.01.003_bib62","first-page":"239","article-title":"The role of antibodies against TB","author":"Glatman-Freedman","year":"2014","journal-title":"Art Sci. Tuberc. Vaccine Dev."},{"issue":"26","key":"10.1016\/j.tube.2019.01.003_bib63","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.1073\/pnas.95.26.15688","article-title":"A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival","volume":"95","author":"Teitelbaum","year":"1998","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.femsim.2004.01.004","article-title":"Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge","volume":"41","author":"Chambers","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2249.2004.02593.x","article-title":"A mycobacterial lipoarabinomannan specific monoclonal antibody and its F (ab') 2 fragment prolong survival of mice infected with Mycobacterium tuberculosis","volume":"138","author":"Hamasur","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib66","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/IAI.68.1.335-341.2000","article-title":"Clearance and organ distribution ofMycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M","volume":"68","author":"Glatman-Freedman","year":"2000","journal-title":"Infect Immun"},{"issue":"6843","key":"10.1016\/j.tube.2019.01.003_bib67","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib68","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1089\/dna.2017.4066","article-title":"Insights into macrophage autophagy in latent tuberculosis infection: role of heat shock protein 16.3","volume":"37","author":"Zhang","year":"2018","journal-title":"DNA Cell Biol"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib69","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/sji.12556","article-title":"Subunit vaccines consisting of antigens from dormant and replicating bacteria show promising therapeutic effect against Mycobacterium bovis BCG latent infection","volume":"85","author":"Li","year":"2017","journal-title":"Scand J Immunol"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib70","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2013.11.065","article-title":"Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis","volume":"32","author":"Singh","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000024370","article-title":"Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery","volume":"122","author":"Falero-Diaz","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib72","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2567.2004.01809.x","article-title":"Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs","volume":"111","author":"Williams","year":"2004","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib73","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijmm.2008.10.007","article-title":"Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16 kDa protein in a model of progressive pulmonary infection","volume":"299","author":"L\u00f3pez","year":"2009","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.tube.2019.01.003_bib74","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1003189","article-title":"A novel human IgA monoclonal antibody protects against tuberculosis","author":"Balu","year":"2011","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.tube.2019.01.003_bib75","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2172-14-S1-S3","article-title":"Passive administration of purified secretory IgA from human colostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary infection","volume":"14","author":"Alvarez","year":"2013","journal-title":"BMC Immunol"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib76","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tube.2009.02.003","article-title":"Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosis","volume":"89","author":"Olivares","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2019.01.003_bib77","series-title":"Proceedings of the national academy of sciences","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","author":"Li","year":"2017"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib78","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/jb.91.3.975-983.1966","article-title":"Effective nonliving vaccine against experimental tuberculosis in mice","volume":"91","author":"Ribi","year":"1966","journal-title":"J Bacteriol"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib79","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/jb.95.6.2000-2004.1968","article-title":"Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice","volume":"95","author":"Brehmer","year":"1968","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib80","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/infdis\/123.5.527","article-title":"Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the rhesus monkey","volume":"123","author":"Ribi","year":"1971","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib81","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0264-410X(91)90008-T","article-title":"Enhancement of the immune response elicited with foot-and-mouth disease virus vaccines by an extract of the Mycobacterium sp. wall","volume":"9","author":"Berinstein","year":"1991","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib82","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/iai.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib83","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/jnci\/52.5.1571","article-title":"Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets","volume":"52","author":"Zbar","year":"1974","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib84","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1749-6632.1976.tb41700.x","article-title":"Immunotherapy with nonviable microbial components","volume":"277","author":"Ribi","year":"1976","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib85","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/intimm\/dxg091","article-title":"Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the Guinea pig model of tuberculosis","volume":"15","author":"Dascher","year":"2003","journal-title":"Int Immunol"},{"issue":"9","key":"10.1016\/j.tube.2019.01.003_bib86","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/IAI.73.9.5817-5826.2005","article-title":"Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system","volume":"73","author":"Rosenkrands","year":"2005","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.tube.2019.01.003_bib87","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1080\/14760584.2016.1187067","article-title":"Innate signaling by mycobacterial cell wall components and relevance for development of adjuvants for subunit vaccines","volume":"15","author":"Tima","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2019.01.003_bib88","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.0804091","article-title":"Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-Guerin","author":"Andersen","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib89","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1479-0556-5-2","article-title":"Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and Guinea pigs","volume":"5","author":"de Paula","year":"2007","journal-title":"Genet Vaccines Ther"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib90","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/CVI.00148-13","article-title":"A single dose of a DNA vaccine encoding Apa co-encapsulated with 6, 6\u2019-trehalose dimycolate in microspheres conferred long-term protection against tuberculosis in BCG-primed mice","volume":"20","author":"Carl\u00e9tti","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"51","key":"10.1016\/j.tube.2019.01.003_bib91","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/j.vaccine.2011.10.032","article-title":"Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10. 4\u2013HspX","volume":"29","author":"Niu","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.tube.2019.01.003_bib92","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1073\/pnas.1612421114","article-title":"Rational design of adjuvants targeting the C-type lectin Mincle","volume":"114","author":"Decout","year":"2017","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib93","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstr\u00f8m","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.tube.2019.01.003_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015043","article-title":"Syringe free vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles provides strong and prolonged protection against tuberculosis","volume":"5","author":"Christensen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2019.01.003_bib95","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.0900947","article-title":"Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis","author":"Aagaard","year":"2009","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161217","article-title":"Testing the H56 vaccine delivered in 4 different adjuvants as a BCG-booster in a non-human primate model of tuberculosis","volume":"11","author":"Billeskov","year":"2016","journal-title":"PLoS One"},{"issue":"25\u201326","key":"10.1016\/j.tube.2019.01.003_bib97","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0264-410X(03)00274-3","article-title":"Mycobacterium tuberculosis arabinomannan\u2013protein conjugates protect against tuberculosis","volume":"21","author":"Hamasur","year":"2003","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.tube.2019.01.003_bib98","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tube.2004.09.013","article-title":"Nasal boost with adjuvanted heat-killed BCG or arabinomannan\u2013protein conjugate improves primary BCG-induced protection in C57BL\/6 mice","volume":"85","author":"Haile","year":"2005","journal-title":"Tuberculosis"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006250","article-title":"Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine","volume":"13","author":"Prados-Rosales","year":"2017","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib100","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.vaccine.2011.11.055","article-title":"Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection","volume":"30","author":"Parlane","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.tube.2019.01.003_bib101","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.vaccine.2017.01.079","article-title":"Protective efficacy of a lipid antigen vaccine in a Guinea pig model of tuberculosis","volume":"35","author":"Larrouy-Maumus","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib102","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/CVI.00034-08","article-title":"Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone","volume":"15","author":"Wedlock","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"10.1016\/j.tube.2019.01.003_bib103","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00537-18","article-title":"Adjuvant potential of poly-\u03b1-l-glutamine from the cell wall of Mycobacterium tuberculosis","volume":"86","author":"Mani","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2019.01.003_bib104","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-immunol-032414-112008","article-title":"The immunology of CD1-and MR1-restricted T cells","volume":"34","author":"Mori","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tube.2019.01.003_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01365","article-title":"The conventional nature of non-MHC-restricted T cells","volume":"9","author":"Lepore","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2019.01.003_bib106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fimmu.2014.00219","article-title":"The T-cell response to lipid antigens of Mycobacterium tuberculosis","volume":"5","author":"De Libero","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2019.01.003_bib107","series-title":"Cold spring harbor perspectives in medicine","article-title":"Nonclassical T cells and their antigens in tuberculosis","author":"De Libero","year":"2014"},{"issue":"1\u20132","key":"10.1016\/j.tube.2019.01.003_bib108","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2014.07.041","article-title":"A novel antigen-carrier system: the Mycobacterium tuberculosis Acr protein carried by raw starch microparticles","volume":"474","author":"Moreno-Mendieta","year":"2014","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib109","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/apm.12851","article-title":"Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB\/c mice using PLGA and DOTAP adjuvant","volume":"126","author":"Khademi","year":"2018","journal-title":"Apmis"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib110","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1128\/IAI.71.6.3146-3154.2003","article-title":"The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection","volume":"71","author":"Hovav","year":"2003","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib111","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.micinf.2013.09.006","article-title":"Investigations of TB vaccine-induced mucosal protection in mice","volume":"16","author":"Blazevic","year":"2014","journal-title":"Microb Infect"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib112","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1574-695X.2006.00087.x","article-title":"Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration","volume":"47","author":"Giri","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"32","key":"10.1016\/j.tube.2019.01.003_bib113","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2005.03.040","article-title":"Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis","volume":"23","author":"Sable","year":"2005","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib114","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/IAI.70.6.3111-3121.2002","article-title":"Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis","volume":"70","author":"Doherty","year":"2002","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.tube.2019.01.003_bib115","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.tube.2019.01.003_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003683","article-title":"Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31\u00ae adjuvant","volume":"3","author":"Kamath","year":"2008","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.tube.2019.01.003_bib117","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/IAI.72.10.6148-6150.2004","article-title":"Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol Guinea pig model","volume":"72","author":"Olsen","year":"2004","journal-title":"Infect Immun"},{"issue":"21","key":"10.1016\/j.tube.2019.01.003_bib118","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.vaccine.2004.11.051","article-title":"Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6","volume":"23","author":"Langermans","year":"2005","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.tube.2019.01.003_bib119","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B\u2013ESAT-6 adjuvanted with IC31\u00ae promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in na\u00efve human volunteers","volume":"28","author":"van Dissel","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.tube.2019.01.003_bib120","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B\u2013ESAT-6 adjuvanted with IC31\u00ae promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"Van Dissel","year":"2011","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.tube.2019.01.003_bib121","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"van Dissel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2019.01.003_bib122","article-title":"Safety and immunogenicity of H1\/IC31 (R), an adjuvanted TB subunit vaccine. HIV-infected adults with CD4+ lymphocyte counts greater than","volume":"350","author":"Reither","year":"2014"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib123","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.vaccine.2016.11.023","article-title":"H1: IC31 vaccination is safe and induces long-lived TNF-\u03b1+ IL-2+ CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: a randomized trial","volume":"35","author":"Mearns","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005139","article-title":"CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10. 4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination","volume":"4","author":"Elvang","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005930","article-title":"Protection and polyfunctional T cells induced by Ag85B-TB10. 4\/IC31\u00ae against Mycobacterium tuberculosis is highly dependent on the antigen dose","volume":"4","author":"Aagaard","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib126","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.vaccine.2009.10.114","article-title":"Non-clinical efficacy and safety of HyVac4: IC31 vaccine administered in a BCG prime\u2013boost regimen","volume":"28","author":"Skeiky","year":"2010","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.tube.2019.01.003_bib127","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.vaccine.2015.05.036","article-title":"The tuberculosis vaccine H4: IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: a randomized controlled trial","volume":"33","author":"Geldenhuys","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib128","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.vaccine.2017.01.055","article-title":"Safety and immunogenicity of the novel H4: IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: two phase I dose escalation trials","volume":"35","author":"Norrby","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4: IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib131","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J Clin Investig"},{"issue":"33","key":"10.1016\/j.tube.2019.01.003_bib132","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56: IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072185","article-title":"Comparing adjuvanted H28 and modified vaccinia virus ankara expressing H28 in a mouse and a non-human primate tuberculosis model","volume":"8","author":"Billeskov","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib134","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-3083.2011.02531.x","article-title":"Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice","volume":"73","author":"Li","year":"2011","journal-title":"Scand J Immunol"},{"issue":"44","key":"10.1016\/j.tube.2019.01.003_bib135","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1016\/j.vaccine.2009.08.018","article-title":"Fusion protein Ag85B-MPT64190\u2013198-Mtb8. 4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice","volume":"27","author":"Luo","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib136","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1574-695X.2010.00660.x","article-title":"The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10: ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants","volume":"59","author":"Chen","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib137","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1183\/09031936.05.00105404","article-title":"Human immune recognition-based multicomponent subunit vaccines against tuberculosis","volume":"25","author":"Sable","year":"2005","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib138","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1080\/21645515.2015.1037057","article-title":"Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine","volume":"11","author":"Teng","year":"2015","journal-title":"Hum Vaccines Immunother"},{"issue":"20","key":"10.1016\/j.tube.2019.01.003_bib139","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.vaccine.2004.11.030","article-title":"Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c\u2014a member of the esat-6 gene family","volume":"23","author":"Hogarth","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.tube.2019.01.003_bib140","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.vaccine.2007.12.005","article-title":"Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guerin (BCG) in infected mice","volume":"26","author":"Kohama","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib141","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/1348-0421.12340","article-title":"Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin\u2010binding hemagglutinin adhesin antigen","volume":"59","author":"Fukui","year":"2015","journal-title":"Microbiol Immunol"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib142","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.tube.2019.01.003_bib143","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","article-title":"The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected Guinea pigs","volume":"72","author":"Brandt","year":"2004","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib144","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1128\/IAI.74.4.2392-2401.2006","article-title":"Evaluation of the Mtb72F polyprotein vaccine in a rabbit model of tuberculous meningitis","volume":"74","author":"Tsenova","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2019.01.003_bib145","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0712077106","article-title":"Defined tuberculosis vaccine, Mtb72F\/AS02A, evidence of protection in cynomolgus monkeys","author":"Reed","year":"2009","journal-title":"Proc Natl Acad Sci Unit States Am"},{"issue":"7","key":"10.1016\/j.tube.2019.01.003_bib146","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/hv.8570","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02A: tolerability and immunogenicity in humans","volume":"5","author":"Von Eschen","year":"2009","journal-title":"Hum Vaccine"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib147","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tube.2012.10.011","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02 in PPD positive adults: a randomized controlled phase I\/II study","volume":"93","author":"Spertini","year":"2013","journal-title":"Tuberculosis"},{"issue":"11","key":"10.1016\/j.tube.2019.01.003_bib148","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/CVI.00133-10","article-title":"Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F\/AS02A candidate tuberculosis vaccine in purified protein derivative-negative adults","volume":"17","author":"Leroux-Roels","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"17","key":"10.1016\/j.tube.2019.01.003_bib149","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","article-title":"Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial","volume":"31","author":"Leroux-Roels","year":"2013","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.tube.2019.01.003_bib150","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tube.2006.01.014","article-title":"Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a Guinea pig aerosol infection model of tuberculosis","volume":"86","author":"Vipond","year":"2006","journal-title":"Tuberculosis"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib151","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1574-695X.1994.tb00433.x","article-title":"Induction of immunity against experimental tuberculosis with mycobacterial mannophosphoinositides encapsulated in liposomes containing lipid A","volume":"8","author":"Singh","year":"1994","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib152","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/jb.100.1.95-102.1969","article-title":"Granuloma formation induced in mice by chemically defined mycobacterial fractions","volume":"100","author":"Bekierkunst","year":"1969","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib153","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/iai.7.1.14-21.1973","article-title":"Effect of anti-cord factor antibody on experimental tuberculosis in mice","volume":"7","author":"Kato","year":"1973","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2019.01.003_bib154","series-title":"Plasmids: biology and impact in biotechnology and discovery","first-page":"651","article-title":"Using plasmids as DNA vaccines for infectious diseases","author":"Tregoning","year":"2015"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib155","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1517\/14712598.2014.951630","article-title":"DNA vaccines against tuberculosis","volume":"14","author":"Bruffaerts","year":"2014","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib156","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2249.2000.01212.x","article-title":"The 19\u2010kD antigen and protective immunity in a murine model of tuberculosis","volume":"120","author":"Yeremeev","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"21\u201322","key":"10.1016\/j.tube.2019.01.003_bib157","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.vaccine.2004.05.005","article-title":"Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles","volume":"22","author":"Mollenkopf","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib158","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/IAI.71.1.575-579.2003","article-title":"Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A","volume":"71","author":"Kirman","year":"2003","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib159","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1472-9792(03)00054-4","article-title":"Vaccination of Guinea pigs with DNA encoding Ag85A by gene gun bombardment","volume":"83","author":"Sugawara","year":"2003","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib160","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1196\/annals.1352.030","article-title":"Novel bacterial delivery system with attenuated Salmonella typhimurium carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse model","volume":"1056","author":"Parida","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib161","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/CVI.00151-06","article-title":"DNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB\/c mice","volume":"13","author":"Teixeira","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib162","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/IAI.69.6.4174-4176.2001","article-title":"Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis","volume":"69","author":"Feng","year":"2001","journal-title":"Infect Immun"},{"issue":"9\u201310","key":"10.1016\/j.tube.2019.01.003_bib163","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.micinf.2006.04.025","article-title":"A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens","volume":"8","author":"Grover","year":"2006","journal-title":"Microb Infect"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib164","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/dna.2006.25.438","article-title":"A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge","volume":"25","author":"Cai","year":"2006","journal-title":"DNA Cell Biol"},{"issue":"10","key":"10.1016\/j.tube.2019.01.003_bib165","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/dna.2005.24.605","article-title":"Coadministration of interleukin 2 plasmid DNA with combined DNA vaccines significantly enhances the protective efficacy against Mycobacterium tuberculosis","volume":"24","author":"Cai","year":"2005","journal-title":"DNA Cell Biol"},{"issue":"30","key":"10.1016\/j.tube.2019.01.003_bib166","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1016\/j.vaccine.2005.03.025","article-title":"Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection","volume":"23","author":"Cai","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib167","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.70.1.292-302.2002","article-title":"DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis","volume":"70","author":"Delogu","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib168","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2567.2003.01589.x","article-title":"A DNA prime\u2010live vaccine boost strategy in mice can augment IFN\u2010\u03b3 responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis","volume":"108","author":"Skinner","year":"2003","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib169","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.vaccine.2004.07.036","article-title":"A polyvalent DNA vaccine expressing an ESAT6\u2013Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity","volume":"23","author":"Derrick","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/dna.2007.0648","article-title":"Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis","volume":"27","author":"Chang-hong","year":"2008","journal-title":"DNA Cell Biol"},{"issue":"39","key":"10.1016\/j.tube.2019.01.003_bib171","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1016\/j.vaccine.2009.06.093","article-title":"A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge","volume":"27","author":"Gao","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.tube.2019.01.003_bib172","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1089\/1044549041474742","article-title":"Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis","volume":"23","author":"Cai","year":"2004","journal-title":"DNA Cell Biol"},{"issue":"20\u201322","key":"10.1016\/j.tube.2019.01.003_bib173","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/S0264-410X(01)00012-3","article-title":"Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins","volume":"19","author":"Garapin","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib174","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.vaccine.2009.09.121","article-title":"Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in Guinea pigs","volume":"28","author":"Dey","year":"2009","journal-title":"Vaccine"},{"issue":"48\u201349","key":"10.1016\/j.tube.2019.01.003_bib175","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1016\/j.vaccine.2005.03.056","article-title":"Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis","volume":"23","author":"Khera","year":"2005","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.tube.2019.01.003_bib176","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1016\/j.vaccine.2007.03.052","article-title":"An ESAT-6: CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis","volume":"25","author":"Maue","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.tube.2019.01.003_bib177","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1128\/IAI.67.9.4780-4786.1999","article-title":"Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences","volume":"67","author":"Li","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib178","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0264-410X(03)00543-7","article-title":"Efficacy of DNA\u2013hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo","volume":"22","author":"Lima","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib179","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1479-0556-5-7","article-title":"Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming","volume":"5","author":"Gon\u00e7alves","year":"2007","journal-title":"Genet Vaccines Ther"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.vaccine.2005.07.115","article-title":"Protective efficacy induced by Mycobacterium bovis bacille Calmette-Guerin can be augmented in an antigen independent manner by use of non-coding plasmid DNA","volume":"24","author":"Hogarth","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib181","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/IAI.68.3.1040-1047.2000","article-title":"Cloning of the gene encoding a 22-kilodalton cell surface antigen of Mycobacterium bovisBCG and analysis of its potential for DNA vaccination against tuberculosis","volume":"68","author":"Lef\u00e8vre","year":"2000","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib182","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1128\/IAI.68.6.3097-3102.2000","article-title":"DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity","volume":"68","author":"Delogu","year":"2000","journal-title":"Infect Immun"},{"issue":"Supplement_3","key":"10.1016\/j.tube.2019.01.003_bib183","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1086\/313875","article-title":"Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83","volume":"30","author":"Chambers","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib184","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1472-9792(03)00055-6","article-title":"Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis","volume":"83","author":"Wedlock","year":"2003","journal-title":"Tuberculosis"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib185","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4049\/jimmunol.162.2.1113","article-title":"Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors","volume":"162","author":"Tanghe","year":"1999","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib186","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","article-title":"Viral vectors as vaccine platforms: deployment in sight","volume":"23","author":"Rollier","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib187","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1590\/S1517-83822014000400001","article-title":"Live bacterial vaccine vectors: an overview","volume":"45","author":"Silva","year":"2014","journal-title":"Braz J Microbiol"},{"issue":"10","key":"10.1016\/j.tube.2019.01.003_bib188","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"issue":"48","key":"10.1016\/j.tube.2019.01.003_bib189","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1016\/j.vaccine.2015.10.017","article-title":"Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A","volume":"33","author":"Stylianou","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib190","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib191","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","article-title":"Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen","volume":"174","author":"Santosuosso","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib192","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005856","article-title":"Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed Guinea pigs against pulmonary tuberculosis","volume":"4","author":"Xing","year":"2009","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib193","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib194","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/mt.2009.60","article-title":"Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis","volume":"17","author":"Mu","year":"2009","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib195","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"Rado\u0161evi\u0107","year":"2007","journal-title":"Infect Immun"},{"issue":"50","key":"10.1016\/j.tube.2019.01.003_bib196","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1016\/j.vaccine.2016.10.065","article-title":"Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B","volume":"34","author":"Dai","year":"2016","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.tube.2019.01.003_bib197","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1016\/j.vaccine.2010.05.063","article-title":"Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein","volume":"28","author":"Shi","year":"2010","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.tube.2019.01.003_bib198","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.vaccine.2005.01.057","article-title":"Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model","volume":"23","author":"Kita","year":"2005","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib199","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tube.2007.06.002","article-title":"Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis","volume":"87","author":"Sugawara","year":"2007","journal-title":"Tuberculosis"},{"issue":"24","key":"10.1016\/j.tube.2019.01.003_bib200","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1007\/s00253-015-6962-x","article-title":"A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection","volume":"99","author":"Yuan","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib201","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the Guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.tube.2019.01.003_bib202","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib203","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1745-7270.2007.00281.x","article-title":"Immune responses and protective efficacy induced by 85B antigen and early secreted antigenic target-6 kDa antigen fusion protein secreted by recombinant bacille Calmette-Gu\u00e9rin","volume":"39","author":"Shi","year":"2007","journal-title":"Acta Biochim Biophys Sin"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib204","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1574-695X.2007.00322.x","article-title":"Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-\u03b3 confers effective protection against Mycobacterium tuberculosis in C57BL\/6 mice","volume":"51","author":"Xu","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.tube.2019.01.003_bib205","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2172-14-S1-S5","article-title":"Immunogenicity of recombinant Mycobacterium bovis bacille Calmette\u2013Gu\u00e8rin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens","volume":"14","author":"Mohamud","year":"2013","journal-title":"BMC Immunol"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib206","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1128\/IAI.00267-10","article-title":"Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice","volume":"78","author":"Sali","year":"2010","journal-title":"Infect Immun"},{"issue":"15","key":"10.1016\/j.tube.2019.01.003_bib207","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2013.11.108","article-title":"Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization","volume":"32","author":"Watanabe","year":"2014","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib208","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/CVI.00056-06","article-title":"Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge","volume":"13","author":"Sereinig","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib209","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijmyco.2015.09.006","article-title":"Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice","volume":"5","author":"Kadir","year":"2016","journal-title":"Int J Mycobact"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1574-695X.2000.tb01441.x","article-title":"Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG","volume":"27","author":"Hess","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"28\u201329","key":"10.1016\/j.tube.2019.01.003_bib211","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1016\/S0264-410X(01)00109-8","article-title":"Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA","volume":"19","author":"Mollenkopf","year":"2001","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.tube.2019.01.003_bib212","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2009.09.007","article-title":"Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B\u2013ESAT6 fusion protein","volume":"27","author":"Hall","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib213","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib214","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/IAI.73.6.3814-3816.2005","article-title":"Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in Guinea pigs","volume":"73","author":"Williams","year":"2005","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib215","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/CVI.00690-12","article-title":"An evaluation of the safety and immunogenicity of a candidate TB vaccine, MVA85A, delivered by aerosol to the lungs of macaques","volume":"20","author":"White","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"10.1016\/j.tube.2019.01.003_bib216","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial","volume":"14","author":"Satti","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"9871","key":"10.1016\/j.tube.2019.01.003_bib217","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib218","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-3083.2011.02629.x","article-title":"Subcutaneous administration of modified vaccinia virus ankara expressing an Ag85B\u2010ESAT6 fusion protein, but not an adenovirus\u2010based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis","volume":"75","author":"You","year":"2012","journal-title":"Scand J Immunol"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib219","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/CVI.00006-10","article-title":"Highly persistent and effective prime\/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant","volume":"17","author":"Kolibab","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib220","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/mt.2008.59","article-title":"Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus\u2013vectored tuberculosis vaccine","volume":"16","author":"Roediger","year":"2008","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib221","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1080\/21645515.2016.1261229","article-title":"Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection","volume":"13","author":"Zhang","year":"2017","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tube.2019.01.003_bib222","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fcimb.2017.00034","article-title":"Vesicular stomatitis virus-vectored multi-antigen tuberculosis vaccine limits bacterial proliferation in mice following a single intranasal dose","volume":"7","author":"Zhang","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib223","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-3083.2007.02031.x","article-title":"Protection of mice against Mycobacterium tuberculosis infection by immunization with aqueous fraction of Triton X\u2010100\u2010soluble cell wall proteins","volume":"67","author":"Jeon","year":"2008","journal-title":"Scand J Immunol"},{"issue":"6","key":"10.1016\/j.tube.2019.01.003_bib224","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1183\/09031936.93.06060811","article-title":"Immunoprotective behaviour of liposome entrapped cell wall subunit of Mycobacterium tuberculosis against experimental tuberculous infection in mice","volume":"6","author":"Chugh","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2019.01.003_bib225","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/273129","article-title":"Protective effect of a lipid-based preparation from Mycobacterium smegmatis in a murine model of progressive pulmonary tuberculosis","volume":"2014","author":"Garc\u00eda","year":"2014","journal-title":"BioMed Res Int"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib226","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1128\/CVI.00094-08","article-title":"Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and Guinea pig experimental models of tuberculosis","volume":"15","author":"Guirado","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib227","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020404","article-title":"Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis","volume":"6","author":"Vilaplana","year":"2011","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib228","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.vaccine.2009.09.134","article-title":"Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI\u00ae","volume":"28","author":"Vilaplana","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.tube.2019.01.003_bib229","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089612","article-title":"Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection","volume":"9","author":"Nell","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.tube.2019.01.003_bib230","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","volume":"10","author":"van der Pol","year":"2015","journal-title":"Biotechnol J"},{"key":"10.1016\/j.tube.2019.01.003_bib231","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2014.00121","article-title":"Bacterial outer membrane vesicles and vaccine applications","volume":"5","author":"Acevedo","year":"2014","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib232","doi-asserted-by":"crossref","first-page":"fty031","DOI":"10.1093\/femspd\/fty031","article-title":"Mycobacterial extracellular vesicles and host pathogen interactions","volume":"76","author":"Gupta","year":"2018","journal-title":"Pathog Dis"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib233","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00778-18","article-title":"Mycobacterium tuberculosis pst\/SenX3-RegX3 regulates membrane vesicle production independently of ESX-5 activity","volume":"9","author":"White","year":"2018","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.tube.2019.01.003_bib234","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1172\/JCI44261","article-title":"Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice","volume":"121","author":"Prados-Rosales","year":"2011","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib235","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01921-14","article-title":"Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis","volume":"5","author":"Prados-Rosales","year":"2014","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.tube.2019.01.003_bib236","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/21645515.2015.1011566","article-title":"Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis","volume":"11","author":"Tirado","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tube.2019.01.003_bib237","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tube.2016.07.017","article-title":"Mycobacterium smegmatis proteoliposome induce protection in a murine progressive pulmonary tuberculosis model","volume":"101","author":"Tirado","year":"2016","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib238","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/pr2007939","article-title":"Characterization of the Mycobacterium tuberculosis proteome by liquid chromatography mass spectrometry-based proteomics techniques: a comprehensive resource for tuberculosis research","volume":"11","author":"Bell","year":"2011","journal-title":"J Proteome Res"},{"issue":"11","key":"10.1016\/j.tube.2019.01.003_bib239","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1021\/pr1005873","article-title":"Proteomic definition of the cell wall of Mycobacterium tuberculosis","volume":"9","author":"Wolfe","year":"2010","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib240","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1091\/mbc.e04-04-0329","article-title":"Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling","volume":"16","author":"Mawuenyega","year":"2005","journal-title":"Mol Biol Cell"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib241","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13205-017-0972-6","article-title":"Comparative lipidomics of drug sensitive and resistant Mycobacterium tuberculosis reveals altered lipid imprints","volume":"7","author":"Pal","year":"2017","journal-title":"3 Biotech"},{"key":"10.1016\/j.tube.2019.01.003_bib242","series-title":"Mycobacterial lipidomics. molecular genetics of mycobacteria","first-page":"341","author":"Layre","year":"2014"},{"issue":"12","key":"10.1016\/j.tube.2019.01.003_bib243","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1021\/acschembio.7b00797","article-title":"Insights into interactions of mycobacteria with the host innate immune system from a novel array of synthetic mycobacterial glycans","volume":"12","author":"Zheng","year":"2017","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.tube.2019.01.003_bib244","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M114.566489","article-title":"Glycerol monomycolate is a novel ligand for the human, but not mouse macrophage inducible C-type lectin, Mincle","author":"Hattori","year":"2014","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.tube.2019.01.003_bib245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042515","article-title":"Divergent effects of mycobacterial cell wall glycolipids on maturation and function of human monocyte-derived dendritic cells","volume":"7","author":"Mazurek","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib246","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.it.2016.10.009","article-title":"Recognition of mycobacterial lipids by immune receptors","volume":"38","author":"Ishikawa","year":"2017","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.tube.2019.01.003_bib247","first-page":"620","article-title":"T cell recognition of non-peptidic antigens in infectious diseases","volume":"138","author":"Singhal","year":"2013","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.tube.2019.01.003_bib248","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.13588.1","article-title":"Progress and challenges in TB vaccine development","volume":"7","author":"Voss","year":"2018","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.tube.2019.01.003_bib249","doi-asserted-by":"crossref","first-page":"12807","DOI":"10.1038\/s41598-017-12718-4","article-title":"Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane","volume":"7","author":"Chiaradia","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2019.01.003_bib250","series-title":"Research article Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv","author":"M\u00e5len","year":"2010"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979218304943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979218304943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:40:33Z","timestamp":1761468033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979218304943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":250,"alternative-id":["S1472979218304943"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2019.01.003","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis vaccine candidates based on mycobacterial cell envelope components","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}